Compare Adaptive Biotechnologies Corp (ADPT) vs Capital One Financial Corp. (COF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Capital One Financial Corp. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while Capital One Financial Corp. trades at $219.37 (market cap $134.33B). The key difference: Capital One Financial Corp. is far larger — about 33.2× Adaptive Biotechnologies Corp's market cap, and Capital One Financial Corp. pays a 1.46% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | COF | |
|---|---|---|
Market Cap | $4.05B | $134.33B |
Sector | Health | Financials |
52-Week High | $25.45 | $257.94 |
52-Week Low | $12.30 | $176.10 |
Enterprise Value | $4.12B | — |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
